Why the study?
Practice guidelines were needed to provide evidence-based recommendations on the management of neuromuscular monitoring and antagonism of neuromuscular blocking agents during and after general anesthesia to reduce residual neuromuscular blockade.
Population
Patients receiving neuromuscular blocking agents during and after general anesthesia
Design
Evidence-based practice guidelines
Authors
Loading...
Clinicians should adopt recommended monitoring sites and antagonism processes to minimize residual blockade; extends evidence-based standards for safe general anesthesia.
These guidelines establish evidence-based recommendations for the monitoring and antagonism of neuromuscular blockade to prevent residual blockade in patients undergoing general anesthesia.
Thilen et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: